α-Synuclein in Parkinson's disease: getting to the core of the matter. Lancet Neurol 2015;14:785-6.
Hauser, RA. 2015. “α-Synuclein in Parkinson’s Disease: Getting to the Core of the Matter. Lancet Neurol 2015;14:785-6.”. Lancet Neurol.
Search
Search results
818 results found
Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). Mov Disord 2013;28:1823-31.
IPX066: a novel carbidopa-levodopa extended-release formulation. Expert Rev Neurother. 2012;12:133-40.
Hauser, RA. 2012. “IPX066: a Novel Carbidopa-Levodopa Extended-Release Formulation. Expert Rev Neurother. 2012;12:133-40.”. Expert Rev Neurother.
Design innovations and baseline findings in a long-term Parkinson’s trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson’s Disease Long-Term Study-1. Mov Disord 2012; 27:1513-1521.
Elm, JJ, and The NINDS NET-PD Investigators. 2012. “Design Innovations and Baseline Findings in a Long-Term Parkinson’s Trial: The National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson’s Disease Long-Term Study-1. Mov Disord 2012; 27:1513-1521.”. Mov Disord.
MicroRNAs regulation in Parkinson’s disease, and their potential role as diagnostic and therapeutic targets
Shaheen, Nour, Ahmed Shaheen, Mahmoud Osama, Abdulqadir J. Nashwan, Vishal Bharmauria, and Oliver Flouty. 2024. “MicroRNAs Regulation in Parkinson’s Disease, and Their Potential Role As Diagnostic and Therapeutic Targets”. Npj Parkinson’s Disease.
Cardiomyocyte myofilament function in common animal models of heart failure with preserved ejection fraction.
Jani, Vivek P, Navid Koleini, Axel J Fenwick, Thomas E Sharp, Traci T Goodchild, Joseph A Hill, David J Lefer, Anthony Cammarato, and David A Kass. 2024. “Cardiomyocyte Myofilament Function in Common Animal Models of Heart Failure With Preserved Ejection Fraction.”. Journal of Molecular and Cellular Cardiology.
Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease
Zesiewicz, TA, RA Hauser, A Freeman, KL Sullivan, AM Miller, and T Halim. 2009. “Fentanyl-Induced Bradykinesia and Rigidity After Deep Brain Stimulation in a Patient With Parkinson Disease”. Clin Neuropharmacol.
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
Hauser, RA, M Panisset, G Abbruzzese, L Mancione, N Dronamraju, and A Kakarieka. 2009. “Double-Blind Trial of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa in Early Parkinson’s Disease”. Mov Disord.
Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, ...
Connors, JJ, D Sacks, AJ Furlan, WR Selman, RA Hauser, and . 2009. “Training, Competency, and Credentialing Standards for Diagnostic Cervicocerebral Angiography, Carotid Stenting, and Cerebrovascular Intervention: A Joint Statement from the American Academy of Neurology, . ”. J Vasc Interv Radiol.
Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 2011;10:509-519.
Gross, RE, RL Watts, RA Hauser, RA Barkay, H Reichmann, R von Kummer, WG Ondo, E Reissig, W Eisner, and . 2011. “Intrastriatal Transplantation of Microcarrier-Bound Human Retinal Pigment Epithelial Cells versus Sham Surgery in Patients With Advanced Parkinson’s Disease: A Double-Blind, Randomised, Controlled Trial. Lancet Neurol 2011;10:509-519.”. Lancet Neurol.